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The synthesis of nucleotides in the body is centrally controlled by the liver, via salvage or de novo 
synthesis. We reveal a pervasive circadian influence on hepatic nucleotide metabolism, from 
rhythmic gene expression of rate-limiting enzymes to oscillating nucleotide metabolome in WT 
mice. Genetic disruption of the hepatic clock leads to aberrant expression of these enzymes, 
together with anomalous nucleotide rhythms, such as constant low levels of ATP with an excess 
in uric acid, the degradation product of purines. These results clearly demonstrate that the 
hepatic circadian clock orchestrates nucleotide synthesis and degradation. This circadian 
metabolome time-table, obtained using state-of-the-art Capillary Electrophoresis Time-of-Flight 
Mass Spectrometry, will guide further investigations in nucleotide metabolism-related disorders. 
 






The circadian clock synchronises physiology and behaviour to the appropriate time of day and 
endogenously generates rhythms under constant conditions. The clock regulates the 
transcription of thousands of target clock-controlled genes involved in fundamental metabolic 
pathways (Akhtar et al., 2002; Lamia et al., 2008; Panda et al., 2002; Reddy et al., 2006; Ueda 
et al., 2002; Vollmers et al., 2009), but the metabolic consequences of such regulation often 
remain to be described.  
Two essential discoveries, the circadian control of the cell cycle (Matsuo et al., 2003) and DNA 
repair (Kang et al., 2010) in the liver, suggest the supply of nucleotides itself is regulated by the 
circadian clock. Since the liver is a site of active de novo nucleotide synthesis and controls the 
supply of free bases and nucleosides to other tissues for salvage (Barsotti et al., 2002; Cansev, 
2006; Cao et al., 2005; Gasser et al., 1981), the circadian control of hepatic nucleotide 
metabolism will have wide implications for the body.  
To define the role of the hepatic clock in the control of nucleotide metabolism, we analysed 
gene expression and metabolome of wild-type and liver Bmal1-deficient mice (Bmal1
L-/-
), which 
show rhythmic activity and food intake but lack a functional molecular clock in the liver driving 
hepatic physiology (Shimba et al., 2011). We show that the expression of rate-limiting enzymes 
in nucleotide metabolism is under clock-control, and that nucleotides are rhythmic and time-
segregated. In Bmal1
L-/-
 liver, aberrant expression of these enzymes is correlated with the 
disruption of nucleotide rhythms. In particular, ATP and was constantly low and uric acid was 
increased, suggesting inefficient purine synthesis and/or increased degradation. We here provide 
the first integrated transcriptome and metabolome circadian timetable focussed on a single 
metabolic pathway, in order to give insights into the physiological importance of the local 
hepatic clock for nucleotide synthesis, relevant for cancer chemotherapy and for the treatment of 
nucleotide imbalance disorders such as gout. 






The expression of genes involved in purine and pyrimidine nucleotide metabolism (KEGG 
mmu00230 and 00240, initially screened for rhythmic expression in microarray dataset at 
http://circadian.salk.edu) was analysed by quantitative real-time PCR from WT liver samples 
dissected every 4 hours during 24 hours. To avoid external interferences on the endogenous 
circadian clock, mice were housed in constant dark (DD) conditions with food and water ad 
libitum. To investigate the role of the liver circadian clock in the control of nucleotide 
biosynthesis, gene expression was analysed in clock-less liver generated by liver-specific 
disruption of the clock gene Bmal1 (Shimba et al., 2011). The loss of temporal hepatic 
organisation was confirmed by the absence of Bmal1 transcript and the aberrant rhythms of 
clock gene expression (Supplemental figure 1). For the sake of clarity, we only report genes that 
showed significant variations of expression (p<0.05 in one-way ANOVA in WT). The results 
presented here are largely consistent with previous microarray datasets (Vollmers et al., 2009), 
but some genes showing very low-amplitude oscillations on microarray were not significant in 
our analysis.  
Rate-limiting enzymes in de novo nucleotide synthesis  
De novo synthesis of nucleotides, with multiple enzymatic steps mediated by different genes, 
leads to the synthesis of inosine monophosphate (IMP, Fig. 1A) or uridine monophosphate 
(UMP, Fig. 1B), precursors for other nucleotides. The rate-limiting enzymes in the de novo 
synthesis of IMP (Ppat) (Nelson et al., 2008) and UMP (Cad and Umps) (Traut, 2009; Traut and 
Jones, 1977), showed significant circadian rhythms of expression. In Bmal1
L-/-
 liver, their 
expression was significantly affected (Ppat showing elevated levels) but still displayed a 
rhythmic component. 





The de novo synthesis of CTP from UTP is mediated by two enzymes called CTP synthases. 
Two isoforms exist, Ctps (cytosolic) and Ctps2 (mitochondrial), both mediating the rate-limiting 
step in the synthesis of cytidine nucleotides. Ctps expression was circadian but Ctps2 showed 
significant bimodal variations. In Bmal1
L-/-
 liver, both genes still displayed rhythmic expression 
with lower amplitude but with a two-fold increase in baseline. 
Together these data suggest the rhythmic de novo synthesis is under predominant systemic 
control, but modulated by the local liver clock. 
Mitochondrial nucleotide monophosphate kinases  
The phosphorylation of nucleotide monophosphates, mediated by specific kinases, is a critical 
step towards the synthesis of NTPs (Nelson et al., 2008). Among these kinases, only the 
mitochondrial isoforms Ak2, Ak4 (Fig.1A) and Cmpk2 (Fig. 1B) showed significant rhythmic 
expressions. Ak2 and Ak4 showed identical waveforms in WT and were similarly affected in 
Bmal1
L-/-
, showing lower expression with a bimodal pattern. Cmpk2 in contrast showed higher 
expression in Bmal1
L-/-
 but remained rhythmic. This suggests that the rhythmic supply of 
nucleotide diphosphate, ADP in particular, is important in the mitochondria where ATP is 
synthesised. Lower Ak expression but higher Cmpk2 expression may cause an imbalance in 
purine/pyrimidine content. 
dNDP synthesis is controlled by the circadian clock 
Deoxynucleotide synthesis from nucleotide diphosphate is mediated by a single enzyme called 
ribonucleotide reductase M (RRM). RRM is composed of two subunits, RRM1 and RRM2 
(Nelson et al., 2008), the latter being rate-limiting for the activity of the enzyme (Zuckerman et 
al., 2011). Rrm1 expression in liver was constant; while Rrm2 displayed pronounced circadian 
variations (Fig. 1 and Sup. figure 2B). Nadir Rrm2 mRNA levels were three times lower than 
those of Rrm1, while at peak level they were equivalent, suggesting indeed a circadian control of 





RRM activity via regulation of Rrm2 expression. In Bmal1
L-/-
 liver, Rrm2 remained constantly 
low. This particular enzyme is interesting since it operates both on purines and pyrimidines, and 
since the synthesis of dNTPs is specifically for DNA replication and repair. Lower Rrm2 
expression in clock-less liver may cause dNTPs insufficiency and hamper liver regeneration 
after injury. 
Nucleotide degradation and salvage 
The degradation of nucleosides to free bases, an important step for their subsequent salvage by 
other tissues (Balestri et al., 2007; Griffiths and Stratford, 1997; Markert, 1991; Pizzorno et al., 
2002), is mediated by nucleoside phosphorylases. All hepatic nucleoside phosphorylases showed 
significant and high-amplitude rhythmic expression: Pnp (Fig. 1A), Tymp and Upp2 (Fig. 1B). 
Pnp, Tymp and Upp2 were highly expressed in the liver compared to other tissues (Sup. figure 
2A), but Upp1 was barely detectable and was not significant (Sup. figure 2B). In addition, Tk1 
and Tk2, salvaging thymidine to dTMP in the cytoplasm and mitochondria respectively (Munch-
Petersen, 2010), were rhythmically expressed in the liver (Fig. 1B). 
In Bmal1
L-/-
 liver, Upp2 expression lost its peak at CT12 and showed a low bimodal pattern. 
Tymp and Pnp showed increased expression, but with a residual rhythm of lower amplitude. Tk1 
and Tk2 were both significantly affected, showing higher baseline and bimodal expression. 
Together these results suggest that the hepatic clock, together with systemic cues, orchestrate 
nucleotide synthesis and degradation. To test this hypothesis, we quantified circadian liver 
metabolome by Capillary Electrophoresis Time-of-Flight Mass Spectrometry (CE-TOFMS) in WT 
mice, every 4 hours during 24 hours. 
Rhythmic abundance of bases, nucleosides and nucleotides by CE-TOFMS 
CE-TOFMS analysis of liver metabolome revealed pervasive rhythms in free purine and 
pyrimidine bases, nucleosides and nucleotides (Fig. 2A and B).  





The rhythms of IMP and UMP were similar to that of the expression of their own synthetic 
enzymes: Ppat and IMP rose during the day, Cad and Umps peaked at night with UMP. 
The purine nucleotides ADP, ATP, GDP and GTP all had similar phases (Fig. 2A), which is 
consistent with the two parallel branches of the purine pathway. Since ATP allosterically 
regulates the synthesis of GMP from IMP, it is likely that the rhythm observed for ATP drives 
that of GTP. In contrast, all cytidine nucleotides showed significant bimodal patterns (Fig. 2B), 
very similar to Ctps2 expression. In contrast, UDP and UTP did not show significant variations.  
The purine bases adenine and guanine peaked at night, rising at the end of the day in a pattern 
similar to Pnp expression and in antiphase to adenosine and guanosine. Similarly, uridine 
abundance was antiphasic to Upp2 expression. Due to efficient degradation of pyrimidine free 
bases to soluble metabolites in the liver, the uracil rhythm closely mirrored that of uridine an 
order of magnitude lower. Since no cytidine phosphorylase has so far been discovered in 
mammals, it is likely that the rhythms observed for cytidine and cytosine depend mostly on 
digestion. A similar rhythm in cytidine, peaking during the subjective day, was previously 
reported in a partial circadian metabolomics study from mouse plasma (Minami et al., 2009). 
Hierarchical clustering by Pearson correlation (Fig. 2C) revealed that purines are time-
segregated, with nucleotides peaking in the mid-subjective day, followed by nucleosides at 
CT12, then by the adenine and guanine bases at CT16. ATP and GTP originate from the two 
opposite branches of the purine pathway but are perfectly synchronous. Clearly, a tight 
regulation of purines operates, resulting in a constant ratio between ATP and GTP throughout 
the day. Adenosine nucleotides are the most abundant purines (Sup. figure 3A), reflecting their 
metabolic importance. 
Hierarchical clustering of pyrimidines revealed a different pattern (Fig. 2D). Here, the highest 
level of temporal organisation reflected the nature of the base used, either uracil or cytosine. 





This underlines the differences between the two parallel and symmetric branches of the purine 
pathway versus the asymmetric and serial pyrimidine pathway (compare Fig. 1A and B). The 
most abundant pyrimidine is UMP, consistent with it being the precursor for all other 
pyrimidine nucleotides (Supplemental figure 3B).  
Similar to the disrupted rhythmic expression of genes presented in Fig. 1, we predict that the 
nucleotide rhythms presented here will likewise be affected by the loss of the hepatic clock. 
Loss of liver clock affects nucleotide rhythms and abundance 
To determine which nucleotide rhythms and abundance are affected by the loss of the hepatic 




 mice at CT4 and CT16. 
These time points were chosen since they often correspond to high and low nucleotide 
abundance in WT mice. We present the results of this analysis organised in a metabolic map, 
similar to that used in Fig. 1. 
IMP and UMP were little affected by the loss of the liver clock. While circadian time had a 
strongly significant effect on the abundance of both, only UMP showed a significant 
time/genotype interaction in two-way ANOVA. This is reminiscent of Ppat, Cad and Umps 
expression in Fig. 1: while they were affected by the loss of the hepatic clock, a rhythmic 
expression persisted, suggesting systemic control of de novo nucleotide synthesis by rhythmic 
cues.  
AMP significantly increased in Bmal1
L-/-
 liver but ATP remained low, which is consistent with 
the blunted expression pattern of Ak2 and Ak4, resulting in a lower ADP/AMP ratio. The 
opposite branch of the purine pathway appeared similarly but somewhat less affected. GTP 
showed blunted CT4/CT16 fold ratio (genotype/time interaction significantly different in two 
way ANOVA, p<0.05). Together this is consistent with a primary circadian regulation of ATP 
synthesis that in turn drives changes in GTP via allosteric control.  





For pyrimidines, UTP and UDP were significantly lower in Bmal1
L-/-
 liver, despite showing 
non-significant circadian variations in WT mice. CTP and CMP levels at CT4 were similar 
between genotypes, but at CT16 they increased in Bmal1
L-/-
 liver while they decreased in WT, 
suggesting altered phase of synthesis, with higher basal synthesis level in clock-less liver. 
The purine nucleosides adenosine and guanosine were less abundant in Bmal1
L-/-
 liver, but 
showed CT4/CT16 variations as in WT. Adenine base however showed a reduction in the 
CT4/CT16 fold ratio. Low adenosine and blunted adenine rhythm are consistent with higher 
expression levels but lower amplitude rhythm observed for Pnp in Fig. 1. For pyrimidine 
nucleosides, uridine showed increased levels in Bmal1
L-/-
 liver, but cytidine was not affected. 
Interestingly, the degradation product of purine nucleotides, uric acid, whose excess in human 
leads to gout, was elevated in Bmal1
L-/-
 liver, suggesting indeed that the balance between 
synthesis (low ATP levels) and degradation (high urate) of purines is tilted towards degradation. 
Together these data provide direct evidence that the hepatic circadian clock orchestrates the 
entire nucleotide metabolic pathway, in synchrony with systemic cues. 
Discussion 
Nucleotide metabolism within the liver is orchestrated by the hepatic circadian clock but also 
synchronised at the level of the whole organism. Firstly, de novo synthesis appears to respond 
mostly to systemic signals, which is consistent with the restricted feeding/fasting-driven 
rhythmic expression of Ppat, Umps and Cad in clock-deficient animal reported in a previous 
dataset (Vollmers et al., 2009). Secondly, the degradation of all nucleosides to their respective 
free bases appears regulated by the hepatic clock via control of phosphorylases transcription, but 
the rhythmic abundance of nucleosides likely reflects their absorption from food. Indeed, all 
nucleoside variations between CT4 and CT16 show parallel changes in WT and clock-deficient 
liver. Taken together, systemic and local circadian regulation of nucleotide metabolism will 





regulate the amount of free bases and/or nucleosides released into the circulation for salvage, 
while ensuring an appropriately timed flow of newly synthesised nucleotides into the hepatic 
pool. This is especially obvious for purines, since all rhythmic genes involved in the anabolism 
of purines (Ppat, Ak2, Ak4 and Rrm2) show synchronized expression with a peak around CT12, 
in contrast to Pnp peaking at CT20.  
The influence of the hepatic clock is mostly seen in the phosphorylation of nucleotides. All 
nucleotide triphosphates synthesised from their monophosphate forms (ATP, GTP, UTP) show 
lower abundance and/or amplitude in clock-less liver. The blunted Ak2 and Ak4 expression in 
Bmal1
L-/-
 liver is consistent with these observations for ATP and GTP. UTP was not rhythmic in 
WT but its decreased abundance in Bmal1
L-/-
 liver clearly indicates nucleotide synthesis as a 
whole suffers from the loss of the hepatic clock. The same is true for opposite variations of 
cytidine nucleotides. 
The expression rhythms of mitochondrial kinases (Ak2, Ak4, Cmpk2 and Tk2) suggest that timed 
nucleotide conversion is especially important in mitochondria, perhaps because they rely 
exclusively on nucleotide salvage and have a more dynamic genome (Rotig and Poulton, 2009). 
Notably, AKs are critically important in the control of cellular energy homeostasis, by 
regulating the amount of ADP available for the synthesis of ATP (Noma, 2005), 70% of which 
originate from mitochondria. We propose that the constant low levels in Ak2 and Ak4 expression 
may contribute to decreased supply of ADP, in turn leading to low ATP levels, affecting in turn 
the synthesis of other nucleotides. Similarly, overexpression of both Ctps and Ctps2 in Bmal1
L-/-
 
liver is likely to contribute to lower UTP and higher CTP and CMP levels observed in these 
animals.  
Available data on the Arabidopsis circadian transcriptome (Mockler et al., 2007) reveals that 
plant homologues of Rrm2, Ak, Ppat and Cad show a circadian component in their expression. 
Interestingly, most of these homologues are targeted to chloroplasts or mitochondria, where the 





de novo synthesis of nucleotides in plant is located (Zrenner et al., 2006). The evolutionary 
conserved circadian nucleotide synthesis, located in different subcellular compartments, 
essentially times maximal availability of nucleotides when they are required the most. As a 
concrete example in mammals, nucleotide excision repair activity in adult mouse liver and brain 
DNA is maximal at CT12 (Kang et al., 2009; Kang et al., 2010), when Rrm2 expression is 
highest, replenishing the pool of dNTPs. 
 
AMP-activated protein kinase (AMPK), whose activity is allosterically regulated by the 
AMP/ATP ratio, was found to regulate the circadian clock (Lamia et al., 2009). Interestingly, 
the AMP/ATP ratio will change during the day due to constant AMP levels but cyclic ATP 
abundance. The circadian clock thus regulates ATP levels, which may in turn feedback to adjust 
the clock in a complex interplay between metabolism and the clock, the topic of recent reviews 
(Asher and Schibler, 2011; Bass and Takahashi, 2010; Schmutz et al., 2011). The role of 
adenylate kinases, more precisely of Ak2, in the generation of circadian rhythms has even been 
suggested previously (Noma, 2005). To confirm the rhythmic expression of AK2, the variations 
of its protein in the liver are shown in Sup. fig. 4. 
 
An important question that has not been addressed in our study is whether the disruption of 
nucleotide rhythms and abundance leads to pathologies in Bmal1
L-/-
 animals. The increased uric 
acid observed in Bmal1
L-/-
 liver, despite its efficient degradation in mouse liver (as opposed to 
human in which UOX, the enzyme oxidising urate, is a pseudogene), may have pathological 
consequences under special circumstances. In addition, the regenerating liver, as well as 
peripheral tissues with high proliferative rates such as bone marrow or thymus, may be 
adversely affected due to nucleotide imbalances seen in the liver of Bmal1
L-/-
 animals. Further 
investigations will address these possibilities. 







Hepatic nucleotide metabolism is timely orchestrated, from the transcriptional control of rate-
limiting genes to the rhythmic abundance of metabolites. The loss of the local hepatic circadian 
clock causes significant perturbations in the normal rhythms of nucleotides likely affecting the 
physiology of the whole animal. These results represent a novel integrative approach, linking 
transcriptomics with high-end metabolomics, focussing on the circadian control of a well 
characterised metabolic pathway. 






Animals. All experiments were approved by the animal experimentation committee of Kyoto 





were generated as described (Shimba et al., 2011). Male C57BL/6J mice and Bmal1
L-/-
 
mice (8 weeks old) were maintained at 23 ± 1°C with 50 ± 10% relative humidity, three animals 
per cage on a 12 h light/12 h dark cycle (lights on 8:00, lights off 20:00), food and water ad 
libitum. At the end of the last dark phase, light was permanently switched off. On the second 
day in DD, starting from CT0 (CT0 beginning of the endogenous day, CT12 beginning of the 
endogenous night, 8:00 and 20:00 respectively), animals (n=3) were sacrificed every four hours 
under a safe red light and sampled for liver RNA extraction and metabolomics analysis. 
 
RNA extraction and quantitative real-time PCR. Mice were sacrificed by cervical 
dislocation and 50 mg from the left liver lobe were immediately transferred in 1ml Trizol 
(Invitrogen, Tokyo, Japan) and homogenised using TissueLyzer (Qiagen, Tokyo, Japan). 
Homogenates were processed for total RNA extraction (RNeasy, Qiagen), and final RNA 
samples were quantified by Nanodrop spectrophotometer. 1.5 g total RNA from each liver 
sample was reverse-transcribed using VILO (Invitrogen). Quantitative real-time PCR was 
performed on 20 ng cDNA using Platinum SYBR Green qPCR Supermix (Invitrogen) in 
StepOnePlus (Applied Biosystems, Tokyo, Japan). Absolute quantification standards for each 
target cDNA were obtained using band-purified PCR products as templates, synthesised using 
the same primer pairs used in qPCR and verified by sequencing (see primer list in supplemental 
table 1). All PCR products used for standard and quantification were of similar sizes (120-150 
bp) and molecular weight (40 KDa). Data were then normalised using relative expression of 
the housekeeping gene Tbp. 





CE-TOFMS. At the time of liver sample collection for qPCR, another 50mg sample from the 
left liver lobe, adjacent to the fragment previously taken, was excised and immediately 
transferred to a 2 ml tube, then snap-frozen in liquid nitrogen. All samples were kept a few days 
at -80C until analysis. Samples were then sent for CE-TOFMS analysis to Human Metabolome 
Technologies (Tokyo, Japan). See supplemental materials for additional information. 
Statistical analyses. Gene expression and metabolites concentration in wild-type mice were 
analysed by One-way ANOVA. To compare Bmal1
L-/-
 and WT mice, gene expression profiles 
were tested by Two-way ANOVA. All statistical analyses were performed using Graphpad 
Prism 4.0. For hierarchical clustering analysis of liver metabolites, raw concentration data of 
circadian metabolites were normalised and mean centred, and then clustered by Pearson 
Correlation Coefficients (Eisen et al., 1998). This was performed using GenePattern available 
from The Broad Institute. 
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Fig. 1. Rate-limiting enzymes are under transcriptional control by the hepatic circadian 
clock. Gene expression analysis in C57BL/6J and Bmal1
L-/- 
mice, on the second day in constant 
darkness, starting from CT0 (n=3 mice per time points, sampled every 4 hours). One-way 
ANOVA was used to analyse gene expression profiles in WT mice, with significance levels 
given under the legend of each graph. Comparison of gene expression in the liver of C57BL/6J 
and Bmal1
L-/-
 mice was performed by Two-way ANOVA, the significance levels are given 
under the title of each graph in the following order:  interaction/genotype/time with * = p<0.05; 
** = p<0.01; *** = p<0.001. The empty and filled rectangles over the X axis indicate subjective 
day and night, respectively. For visual clarity, data at CT0 is double plotted at CT24 in all 
graphs. (A), Gene expression analysis of enzymes in the purine pathway. A simplified purine 
metabolic pathway is shown in the centre. Note the similar peak times for Ppat, Rrm2, Ak2 and 
Ak4, different from that of Pnp. (B), Gene expression analysis of enzymes in the pyrimidine 
pathway. A simplified pyrimidine metabolic pathway is shown in the centre. Green arrows 
indicate de novo synthesis (multiple enzymatic steps, but rate-limiting enzymes are indicated by 
a green label); blue, NMP kinases; red, NDP reductase; purple, nucleoside phosphorylases. 
Double black lines represent enzymatic activities encoded by non-rhythmic genes. All data 
presented are Mean +/- SEM. 
 
Fig. 2. Rhythmic abundance of free bases, nucleosides and nucleotides in the liver. 
Quantification of purine and pyrimidine nucleotides, nucleosides and free bases in the liver of 
C57BL/6J mice sampled on the second day in constant darkness from CT0 (n= 3 animals per 
time point). Significance levels in One-way ANOVA are given on the upper right corner of each 
graph. The empty and filled rectangles over the X axis indicate subjective day and night, 
respectively. Here, the colour of curves indicate initial nucleotide monophosphate from the de 





novo pathway (green), NDP and NTP (blue) and free bases and nucleosides (purple), 
corresponding to the colours used for the enzyme activities contributing to the regulation of 
these metabolites. For visual clarity, data at CT0 is double plotted at CT24 in all graphs. All 
data presented are Mean +/- SEM. (A), Rhythmic profiles of purine nucleotides, nucleosides 
and free bases. (B), Rhythmic profiles of pyrimidine nucleotides, nucleosides and free bases. 
(C), Hierarchical clustering of purines using Pearson correlation coefficient displayed as a heat 
map. Note the clear clustering between nucleotides, nucleosides and free bases, forming three 
separated time-domains of maximal abundance. (D), Hierarchical clustering of pyrimidines 
using Pearson correlation coefficient displayed as a heat map. Note here the clear higher-order 
clustering between cytidine nucleotides, nucleoside and bases; and UMP, uridine and uracil. All 
data presented are Mean +/- SEM. 
 
Fig. 3. Loss of liver clock affects nucleotide rhythms and abundance. Absolute 




 (WT) mice by 
CE-TOFMS at CT4 and CT16 (n=2). (A), Purine pathway. Note IMP rhythm persists in Bmal1
L-
/-
 liver while ATP remains low. (B), Pyrimidine pathway. Note opposite changes in UTP and 
CTP. Data were analysed by Two-way ANOVA. Significance levels in Two-way ANOVA are 
given under the title of each graph in the following order: interaction/genotype/time, with * = 
p<0.05; ** = p<0.01; *** = p<0.001. All data presented are Mean +/- SD. 
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Supplemental Information Inventory 
-A detailed explanation of the Capillary Electrophoresis Time-Of-Flight Mass-Spectrometry method 
employed. It is related to the data presented in Figure 2. 
-A description of Western Blot method employed for the data of Supplemental Figure 4, which 
supports the data presented in Figure 1. 
-Supplemental Figures: 
- Supplemental Figure 1. Bmal1L-/- mice have disrupted circadian clock in the liver, related to 
Figure 1. Confirms the disruption of liver Bmal1 expression. 
- Supplemental Figure 2. Genes involved in the synthesis and supply of nucleotides are 
strongly expressed in the liver, related to Figure 1. Shows liver-specific expression of genes 
involved in nucleotide metabolism, supporting Figure 1-associated discussion. 
- Supplemental Figure 3. Mean abundance of purine and pyrimidine in the liver, related to 
Figure 2. Shows mean abundance of nucleotides in the liver, supporting Figure 2. 
- Supplemental Figure 4. Variations in AK2 protein quantity in the WT liver across a day in 
constant darkness, related to Figure 1. Shows Ak2 expression in the liver of WT mice, 
supporting Figure 1. 
-Supplemental Table 1: shows the sequence of primers used for real-time PCR data presented in 
Figure 1.  
-Supplemental References: related to the references cited in the extended methods pertaining to 
the CE-TOFMS. 
Inventory of Supplemental Information
Extended experimental procedures 
CE-TOFMS. Frozen liver samples were homogenized (MS-100R; TOMY, Tokyo, Japan) in 500 ml of 
methanol. The homogenate was mixed with chloroform and Milli-Q water, and then centrifuged at 2,300 
g for 5 min at 4℃. Subsequently, the aqueous phase was centrifuged at 9,100 g for 120 min at 4℃ for 
ultra-filtration through a 5 KDa filter (Millipore, Tokyo, Japan) to remove proteins. The filtrate was 
evaporated and dissolved in 50 µL of Milli-Q water for CE-TOFMS analysis. CE-TOFMS was carried 
out using an Agilent CE Capillary Electrophoresis System equipped with an Agilent 6210 Time of Flight 
mass spectrometer, Agilent 1100 isocratic HPLC pump, Agilent G1603A CE-MS adapter kit, and Agilent 
G1607A CE-ESI-MS sprayer kit (Agilent Technologies,Waldbronn, Germany). Metabolite peaks were 
compared to a reference standards database held in Human Metabolome Technologies. 
The system was controlled by Agilent G2201AA ChemStation software version B.03.01 for CE (Agilent 
Technologies, Waldbronn, Germany). Cationic metabolites were analyzed with a fused silica capillary 
(50 μm i.d. × 80 cm total length), with Cation Buffer Solution (Human Metabolome Technologies) as the 
electrolyte and methionine sulfone as internal standard. The sample was injected at a pressure of 50 mbar 
for 10 sec (approximately 10 nl). The applied voltage was set at 27 kV. Electrospray ionization-mass 
spectrometry (ESI-MS) was conducted in the positive ion mode, and the capillary voltage was set at 
4,000 V. The spectrometer was scanned from m/z 50 to 1,000. Other conditions were as in the cation 
analysis (Soga and Heiger, 2000). 
Anionic metabolites were analyzed with a fused silica capillary (50 μm i.d. × 80 cm total length), with 
Anion Buffer Solution (Human Metabolome Technologies) as the electrolyte and PIPES as internal 
standard. The sample was injected at a pressure of 50 mbar for 25 sec (approximately 25 nl). The applied 
voltage was set at 30 kV. ESI-MS was conducted in the negative ion mode, and the capillary voltage was 
set at 3,500 V. The spectrometer was scanned from m/z 50 to 1,000. Other conditions were as in the anion 
analysis (Soga et al., 2007). Raw data obtained by CE-TOFMS were processed with the automatic 
Supplemental Figures and Text
integration software MasterHands (Sugimoto et al., 2010). Peak information including m/z, migration 
time (MT) and area was obtained. Peak area was converted into relative peak area according to the 
equation: Relative peak area=Metabolite Peak Area/(Internal Standard Peak Area × Sample Amount). 
Each peak was aligned according to similar migration time on CE and m/z value determined by TOFMS. 
Near 100 metabolites were identified using this procedure. 
Western Blot. Equivalent amounts of liver tissue (~50 mg) were dissected (n=2 animals per time points 
at CT 0, 4, 8, 12, 16 and 20) and homogenised in 0.5 ml RIPA buffer with a Dounce homogeniser. 
Homogenates were transferred to a 1.5 ml microtube and incubated at 4°C for 20 min, then centrifuged at 
12,000 xg at 4°C for 15 min. The supernatant was aliquoted into new tubes. Protein homogenates were 
mixed with 5x Laemmli buffer, boiled at 95°C for 10 min, centrifuged for 5 min at 12,000 xg, then 
equivalent amounts of proteins (~ 10 g in 15 l) were loaded into each well. Samples were then run on a 
standard Polyacrylamide gel (ATTO pre-cast gel, 12.5%) at 25 mA for 20 min, then at 35 mA for 40 min 
in SDS TRIS-glycine buffer. Samples were then semi-dry blotted onto a PVDF membrane (ATTO, Japan) 
following manufacturer’s protocol. Membrane was blocked with Blocking One (Nacalai Tesque, Japan) 
for 30 min at RT, then simultaneously incubated with anti-AK2 (ProteinTech, 11014-1-AP, x2000) and 
anti--actin (Sigma, A3853, x1000) secondary antibodies overnight at 4°C in TBST. The next day 
membrane was washed three times 5 min in TBST, then incubated in HRP-conjugated secondary 
antibodies (anti-mouse IgG, NA9310, x 50,000; anti-rabbit IgG, NA9340, x50,000) for 1 hour at RT in 
TBST. The membrane was washed three times 5 min at RT in TBST. Bands were visualised using ECL 
prime chemiluminescent reagent (GE Healthcare) following manufacturer’s instructions in a Fujifilm Las-




Supplemental Figure 1. Bmal1
L-/-
 mice have disrupted circadian clock in the liver, related to Figure 
1. Clock gene expression analysis in the liver of WT and Bmal1
L-/-
 mice kept in constant darkness. Real-
time PCR with a primer pair targeted to the deleted Bmal1 region (exon 6 to 8) did not lead to any 
significant amplification; the circadian clock in the liver has efficiently been disrupted. This is confirmed 
with the expression of the canonical clock genes Per1 and Per2 in the liver of the same animals, showing 
severely blunted expression. All data are mean +/- SEM, n = 3. The frame on top of each graph indicate 
significance level of gene expression in wild-type animals in one-way ANOVA (top), followed 
underneath by the comparison of gene expression between WT and Bmal1
L-/-
 animals by Two-way 
ANOVA (Interaction/Time/Genotype). 
 
Supplemental Figure 2. Genes involved in the synthesis and supply of nucleotides are strongly 
expressed in the liver, related to Figure 1. (A), The liver is the main supplier of nucleoside and bases to 
other tissues throughout the body. In agreement to that, expression of Pnp, Upp2 and Tymp, encoding 
nucleoside phosphorylases, is dramatically higher in the liver compared to the adrenal gland or to muscle 
tissue. (B), Rrm2 expression is rhythmic and in limiting amount compared to the Rrm1 subunit (left), 
consistent with RRM2 as the rate-limiting subunit of the whole RRM enzyme. Upp2 expression in the 
liver is 100-fold higher than that of Upp1 (right), indicating that Upp2 encodes the main uridine 
phosphorylase activity detected from the liver.  
 
Supplemental Figure 3. Mean abundance of purine and pyrimidine in the liver, related to Figure 2. 
(A), Mean abundance of purine bases, nucleosides and nucleotides. (B), Mean abundance of pyrimidine 
bases, nucleosides and nucleotides. 
 
Supplemental Figure 4. Variations in AK2 protein quantity in the WT liver across a day in constant 
darkness, related to Figure 1. AK2 (lower bands at 26 KDa) and -Actin (upper bands at 42 KDa) 
proteins were visualised on the same membrane using different primary and secondary antibodies. n = 2 
animals per time point, their corresponding sample loaded sequentially in two CT0-20 series. Note the 
higher intensity of bands at CT12-20. 
Supplemental Table 1 
Sequence of primers used for quantitative real-time PCR 
Target 
gene  
Sense primer (5'-3') Antisense primer (5'-3') 
Ak2 GGAGGATCACTGGGAGGCTGAT CGTTGTCATCTGACCTGCGGA 
Ak4 GGGAGGGTCTATAACCTGGAC TCCTTGTACCGTCTTAGCCTG 
Bmal1 AGGCGTCGGGACAAAATGAACA TGGGTTGGTGGCACCTCTCA 
Cad AGAAAGGGACAGAGCCGTCAG ATCCAGAGCACAGATCCGAGG 
Cmpk2 CTGCTTAACTCTGCGGTGTTC CTTTCTGGACCTCCTTTGGGC 
Ctps GGAAGACTGTCCAGGTTGTCCC AATGTCTCCCACTGTGCCACC 
Ctps2 AGCCAGTCACCAAAGCCGAGGA CCTTGCCCACGAAATTGCCTG 
Dpyd CCACCGCAGCCAAGAAACTAG TCGCTCACCAAGAGTCGTGTG 
Per1 TGGCTCAAGTGGCAATGAGTC GGCTCGAGCTGACTGTTCACT 
Per2 CCATCCACAAGAAGATCCTAC GCTCCACGGGTTGATGAAGC 
Pnp TTAGGAGGGCTGACTGCTCAC GCATCATCACACAGGATCTGC 
Ppat GGGTATTGGGCTTTCCACGTC TAACCAGGGAGTATGCTGCGG 
Rrm1 CACCCTGACTATGCCATCCTGG GAGAGTGTCTGCCGTTGTGCG 
Rrm2 CTGTTTCTATGGCTTCCAAAT TTCTTCTTCACACAAGGCATT 
Tk1 CGGAGAGTGTGGTGAAGCTCA CACGGAGTGATACTTGTCGGC 
Tk2 TCCAAGACCCCATCACTCTCTC TGACTTCTTCATGCTCGTGGTC 
Tymp AGGTCCCTTCACCCTTCGCTGA CCTAGAGCCAGTAGCATCGTG 
Umps GGCGACAGTTATCTGCTCAGC CGTCCTCAATGACCAGACAGG 
Upp1 CCTCAGCACTAGCACACACGA GGATATTCCTTCCCTGGATGG 
Upp2 CGGTTGGAGGGAGATGGAGAA AATGGAAATGGAGGGGATGCC 
Supplemental table 1 Sequences of oligonucleotide primers used in qPCR in Figure 1. 
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